levofloxacin has been researched along with Group A Strep Infection in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (13.46) | 18.2507 |
2000's | 15 (28.85) | 29.6817 |
2010's | 20 (38.46) | 24.3611 |
2020's | 10 (19.23) | 2.80 |
Authors | Studies |
---|---|
Larruskain, J; Montes, M; Orden, B; Perez-Trallero, E; Tamayo, E | 1 |
Melo-Cristino, J; Pinho, MD; Ramirez, M | 1 |
Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I | 1 |
Kim, ES; Kim, HB; Lee, H; Park, JS; Park, KU; Song, KH | 1 |
Chen, S; Kou, Z; Li, R; Liu, Y; Wang, Q; Wang, X | 1 |
Bao, J; Chen, Y; Dong, R; Li, N; Lin, M; Pan, X; Su, Z; Wang, G; Wang, J; Zhang, T; Zhang, Y; Zou, P | 1 |
Huang, IW; Huang, TW; Huang, YC; Kuo, SC; Lai, JF; Lauderdale, TL; Liao, CL; Wu, CJ | 1 |
Ardura, MI; Klamer, BG; Oyeniran, SJ; Quintero, AM; Vidal, DAC | 1 |
Lopez de Hierro-Ruiz, M; Lopez-Tobaruela, JM; Redondo-Cerezo, E; Valverde-Lopez, F | 1 |
Hirai, N; Hishiya, N; Ichimura, S; Kasahara, K; Nakano, A; Nakano, R; Ogawa, M; Ogawa, Y; Suzuki, Y; Yano, H; Yoshikawa, M | 1 |
Congia, S; Conte, M; Dessì, G; Donadu, MG; Marongiu, G; Mazzarello, V; Verderosa, V; Verona, M | 1 |
Imuta, N; Iuchi, H; Kiyama, S; Kurono, Y; Nishi, J; Ohori, J; Yamashita, M | 1 |
Bai, R; Ge, Y; Ji, W; Mao, Y; Pan, F; Tong, H; Wang, F | 1 |
Bagnarelli, P; Brenciani, A; Giovanetti, E; Mingoia, M; Morroni, G; Simoni, S; Varaldo, PE; Vincenzi, C | 1 |
Hsieh, LY; Huang, IW; Lai, JF; Lauderdale, TL; Shiau, YR; Wang, HY; Wu, CJ | 1 |
Abgueguen, P; Ansart, S; Arvieux, C; Asseray, N; Bernard, L; Cormier, H; Dubée, V; Le Moal, G; Legrand, E; Lemarié, C; Mahieu, R; Ramanantsoa, C; Seegers, V | 1 |
Balaji, K; Pandian, SK; Thenmozhi, R | 1 |
Bernaschi, P; Di Luca, MC; Petrelli, D; Prenna, M; Repetto, A; Vitali, LA | 1 |
Chang, J; Kim, YK; Park, YJ; Ryu, H; Yu, JK | 1 |
Bolaños-Rivero, M; Navarro-Navarro, R; Pisos-Álamo, E; Zarrif, H | 1 |
Calabuig Muñoz, E; Garrido Jareño, M; López-Hontangas, JL; Valentín Martín, A | 1 |
Biscaro, V; Caruso, A; De Francesco, MA; Gargiulo, F; Piccinelli, G | 1 |
Imöhl, M; van der Linden, M | 1 |
Fernández, C; López-Garrido, B; Losa, C; Medina-Pascual, MJ; Pérez-Balsalobre, M; Sáez-Nieto, JA; Tena, D | 1 |
Attisano, C; Cibinel, M; Furfaro, G; Giardini, F; Grandi, G; Grignolo, FM; Machetta, F; Panepinto, G; Pollino, C; Strani, G | 1 |
Abe, M; Araoka, H; Asano-Mori, Y; Hishinuma, A; Ishiwata, K; Izutsu, K; Kageyama, K; Kaji, D; Kimura, M; Nishida, A; Okamoto, Y; Takagi, S; Taniguchi, S; Uchida, N; Wake, A; Yamamoto, G; Yamamoto, H; Yoneyama, A; Yoshida, A; Yuasa, M | 1 |
Beltrand, E; Blondiaux, N; Brunschweiler, B; Canarelli, JP; Caron, F; Cattoir, V; Dujardin, F; El Samad, Y; Etienne, M; Fiaux, E; Frebourg, N; Hulet, C; Loiez, C; Lora-Tamayo, J; Migaud, H; Nguyen, S; Robineau, O; Senneville, E; Titecat, M; Valette, M | 1 |
Murayama, SY; Nakayama, E; Sunakawa, K; Sunaoshi, K; Ubukata, K; Wajima, T | 1 |
Coronel, P; del Prado, G; Díaz, C; García-Rodas, R; Gimeno, M; Gracia, M; Granizo, JJ; Huelves, L; Naves, PF; Ponte, MC; Rodríguez-Cerrato, V; Ruiz, V; Soriano, F | 1 |
Ambruzs, M; Fisher, AC; Nord, CE; Peterson, J | 1 |
Dinani, A; Ktaich, N; Rubin, D; Urban, C | 1 |
Castillo, FJ; Durán, E; Gómez-Lus, R; Llaneza, E; Rubio-Calvo, C; Seral, C | 1 |
George, R; Martin, S; Moyce, L; Orr, D; Pichon, B; Wilkinson, P | 1 |
Feldman, D; Sarabanchong, VO; Treszezamsky, AD | 1 |
Cao, B; Chu, Y; He, W; Hu, B; Hu, Z; Liao, K; Mei, Y; Ni, Y; Sun, Z; Wang, H; Xu, Y; Yang, Q; Yu, Y; Zhang, F; Zhang, L; Zhao, C | 1 |
Almer, LS; Diekema, DJ; Doern, GV; Flamm, RK; Heilmann, KP; Richter, SS; Shortridge, VD; Zeitler, R | 1 |
Marchetti, F; Trinchieri, A | 1 |
Bisquert Santiago, J; Gimeno Fernández, C; González Praetorius, A; Pérez Pomata, MT; Robres Guillén, P; Rodríguez-Zurita, ME; Solís del Baño, S | 1 |
Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J | 1 |
Al-Lahham, A; Lütticken, R; Reinert, RR | 1 |
Coll, P; Mirelis, B; Miró, E; Navarro, F; Rebollo, M; Rivera, A; Sánchez, F | 1 |
Hiyama, L; Miller, LG; Tang, A | 1 |
Alonso, R; Cisterna, R; Ezpeleta, G; Mateo, E | 1 |
Plouffe, JF | 1 |
Jones, RN; Pfaller, MA | 1 |
Tuohy, M; Washington, JA | 1 |
Domon, H; Miyazaki, S; Yamaguchi, K; Yoshizumi, S | 1 |
Jasovich, A; Neto, W; Nicodemo, AC; Robledo, JA | 1 |
Chambers, HF; Chow, LL; Hackbarth, C; Xiang, Q | 1 |
Caldelari, I; Entenza, JM; Glauser, MP; Moreillon, P | 1 |
Grant, EM; Nightingale, CH; Quintiliani, R | 1 |
Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I | 1 |
3 review(s) available for levofloxacin and Group A Strep Infection
Article | Year |
---|---|
Maternal colonization with group B Streptococcus and antibiotic resistance in China: systematic review and meta-analyses.
Topics: Anti-Bacterial Agents; China; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pregnancy; Streptococcal Infections; Streptococcus agalactiae; Tetracycline | 2023 |
Late onset periprosthetic joint infection of the knee caused by Streptococcus anginosus. Case presentation and literature review.
Topics: Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Humans; Knee Joint; Levofloxacin; Male; Reoperation; Streptococcal Infections; Streptococcus anginosus; Vancomycin | 2021 |
Pharmacodynamics and pharmacokinetics of levofloxacin.
Topics: Anti-Infective Agents; Area Under Curve; Cost-Benefit Analysis; Cross Infection; Drug Costs; Humans; Levofloxacin; Ofloxacin; Streptococcal Infections; Streptococcus pneumoniae | 2000 |
3 trial(s) available for levofloxacin and Group A Strep Infection
Article | Year |
---|---|
Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial- resistant streptococci in the microflora of healthy adults.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Microbial Viability; Ofloxacin; Oropharynx; Streptococcaceae; Streptococcal Infections; Young Adult | 2009 |
[Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
Topics: Anti-Infective Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Follow-Up Studies; Humans; Levofloxacin; Ofloxacin; Pseudomonas Infections; Recurrence; Safety; Staphylococcal Infections; Streptococcal Infections; Superinfection; Treatment Outcome; Urinary Tract; Urinary Tract Infections | 2003 |
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Skin Diseases, Bacterial; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 1998 |
46 other study(ies) available for levofloxacin and Group A Strep Infection
Article | Year |
---|---|
Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
Topics: Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Mutation; Prospective Studies; Spain; Streptococcal Infections; Streptococcus pyogenes | 2010 |
Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gene Pool; Humans; Levofloxacin; Molecular Sequence Data; Ofloxacin; Phylogeny; Point Mutation; Streptococcal Infections; Streptococcus; Streptococcus pyogenes | 2010 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes | 2010 |
Clinical and molecular epidemiology of invasive group B Streptococcus infections in adults in a referral center in Korea.
Topics: Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Humans; Infant; Levofloxacin; Molecular Epidemiology; Multilocus Sequence Typing; Referral and Consultation; Serogroup; Serotyping; Streptococcal Infections; Streptococcus agalactiae | 2022 |
Case report: One human Streptococcus suis occurred in Shandong Province, China.
Topics: Aged; Animals; China; Humans; Levofloxacin; Male; Sepsis; Streptococcal Infections; Streptococcus suis; Swine; Zoonoses | 2022 |
High-level levofloxacin-resistant emm12 group A Streptococcus, 2012-2018: A multicenter study in Taiwan.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Hong Kong; Humans; Levofloxacin; Microbial Sensitivity Tests; Scarlet Fever; Streptococcal Infections; Streptococcus pyogenes; Taiwan | 2023 |
Emerging Resistance Trends in Viridans Group Streptococci Bloodstream Infections Among Immunocompromised Children Receiving Levofloxacin Prophylaxis.
Topics: Anti-Bacterial Agents; Bacteremia; Child; Humans; Levofloxacin; Microbial Sensitivity Tests; Streptococcal Infections; Viridans Streptococci | 2023 |
Hepatic Abscess After Biodegradable Esophageal Stent Placement: A Rare Complication.
Topics: Absorbable Implants; Anti-Bacterial Agents; Chemoradiotherapy; Drainage; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophageal Stenosis; Esophagoscopy; Female; Humans; Levofloxacin; Liver Abscess; Middle Aged; Postoperative Complications; Stents; Streptococcal Infections; Streptococcus intermedius | 2021 |
Clinical characteristics and molecular epidemiology of invasive Streptococcus agalactiae infections between 2007 and 2016 in Nara, Japan.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Serogroup; Serotyping; Streptococcal Infections; Streptococcus agalactiae | 2020 |
Effectiveness of antibacterial agents against cell-invading bacteria such as Streptococcus pyogenes and Haemophilus influenzae.
Topics: Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Streptococcal Infections; Streptococcus pyogenes | 2021 |
Prevalence of group B streptococcus colonization in pregnant women in Jiangsu, East China.
Topics: Adolescent; Adult; Anti-Bacterial Agents; China; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant, Newborn; Levofloxacin; Middle Aged; Neonatal Sepsis; Penicillins; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Prevalence; Retrospective Studies; Streptococcal Infections; Streptococcus agalactiae; Vagina; Young Adult | 2021 |
Molecular Characterization of Italian Isolates of Fluoroquinolone-Resistant Streptococcus agalactiae and Relationships with Chloramphenicol Resistance.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Typing Techniques; Chloramphenicol; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Gene Expression; Genotype; Humans; Italy; Levofloxacin; Microbial Sensitivity Tests; Phylogeny; Streptococcal Infections; Streptococcus agalactiae | 2018 |
Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; DNA Mutational Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Hospitals; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Middle Aged; Multilocus Sequence Typing; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Taiwan; Young Adult | 2017 |
The prognosis of streptococcal prosthetic bone and joint infections depends on surgical management-A multicenter retrospective study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Hip Prosthesis; Humans; Joint Diseases; Knee Prosthesis; Levofloxacin; Male; Prognosis; Prosthesis-Related Infections; Recurrence; Retrospective Studies; Rifampin; Streptococcal Infections; Streptococcus; Streptococcus agalactiae; Treatment Failure; Treatment Outcome | 2019 |
Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Scanning; Norfloxacin; Ofloxacin; Streptococcal Infections; Streptococcus pyogenes; Virulence | 2013 |
Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant; Italy; Levofloxacin; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Prevalence; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus pyogenes | 2014 |
Dominance of clonal complex 10 among the levofloxacin-resistant Streptococcus agalactiae isolated from bacteremic patients in a Korean hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Middle Aged; Multilocus Sequence Typing; Republic of Korea; Streptococcal Infections; Streptococcus agalactiae; Young Adult | 2014 |
[Spondylodiscitis by Streptococcus dysgalactiae subsp. equisimilis (group G)].
Topics: Clindamycin; Discitis; Drug Hypersensitivity; Drug Substitution; Female; Humans; Levofloxacin; Low Back Pain; Lumbar Vertebrae; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging; Rifampin; Streptococcal Infections; Streptococcus | 2014 |
[Hip prosthesis infection due to Streptococcus gallolyticus subsp. pasteurianus].
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Cephalosporins; Device Removal; Drug Substitution; Female; Foreign-Body Reaction; Hip Prosthesis; Humans; Levofloxacin; Prosthesis Failure; Prosthesis-Related Infections; Reoperation; Streptococcal Infections; Streptococcus gallolyticus; Synovial Fluid | 2015 |
Characterization and antibiotic susceptibility of Streptococcus agalactiae isolates causing urinary tract infections.
Topics: Anti-Bacterial Agents; Cefaclor; Ceftriaxone; Cefuroxime; Disk Diffusion Antimicrobial Tests; DNA Gyrase; Drug Resistance, Bacterial; Erythromycin; Humans; Levofloxacin; Penicillins; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Urinary Tract Infections | 2015 |
Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.
Topics: Anti-Bacterial Agents; Cefotaxime; Chloramphenicol; Clindamycin; Epidemiological Monitoring; Germany; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Penicillins; Streptococcal Infections; Streptococcus pyogenes; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2015 |
Lactational mastitis caused by Streptococcus lactarius.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Levofloxacin; Mastitis; Molecular Diagnostic Techniques; Streptococcal Infections; Streptococcus; Treatment Outcome | 2016 |
Severe Ocular Bacterial Infections: A Retrospective Study Over 13 Years.
Topics: Anti-Bacterial Agents; Conjunctiva; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2017 |
Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospitals; Humans; Japan; Levofloxacin; Male; Middle Aged; Retrospective Studies; Streptococcal Infections; Transplantation Conditioning; Transplantation, Homologous; Viridans Streptococci; Young Adult | 2016 |
Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis; Arthroplasty, Replacement, Knee; Drug Therapy, Combination; Female; Hip Prosthesis; Humans; Knee Joint; Knee Prosthesis; Levofloxacin; Male; Middle Aged; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Streptococcal Infections; Treatment Outcome | 2016 |
Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Carrier Proteins; Child; Child, Preschool; Humans; Infant; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; Streptococcal Infections; Streptococcus pyogenes | 2008 |
Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Child; Drug Resistance, Bacterial; Europe; Female; Humans; Levofloxacin; Macrolides; Male; Microbial Sensitivity Tests; Ofloxacin; Streptococcal Infections; Streptococcus pyogenes; Young Adult | 2009 |
Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis.
Topics: Aged; Aged, 80 and over; Drug Resistance, Bacterial; Echocardiography; Endocarditis, Subacute Bacterial; Endophthalmitis; Humans; Levofloxacin; Male; Ofloxacin; Streptococcal Infections; Streptococcus mitis | 2009 |
Characterization of clinical blood isolates of Streptococcus agalactiae with reduced susceptibility to levofloxacin.
Topics: Agglutination Tests; Anti-Bacterial Agents; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies; Streptococcal Infections; Streptococcus agalactiae | 2009 |
Incidence and epidemiology of levofloxacin resistance in Streptococcus pneumoniae: experience from a tertiary referral hospital in England.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; DNA Fingerprinting; DNA Gyrase; DNA Topoisomerase IV; England; Female; Genotype; Hospitals, Teaching; Humans; Incidence; Infant; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Sequence Analysis, DNA; Serotyping; Streptococcal Infections; Streptococcus pneumoniae; Young Adult | 2010 |
Concurrent postpartum uterine and abdominal wall dehiscence and Streptococcus anginosus infection.
Topics: Abdominal Wall; Acute Disease; Adolescent; Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Cesarean Section; Chorioamnionitis; Female; Humans; Levofloxacin; Metronidazole; Ofloxacin; Postoperative Complications; Postpartum Period; Pregnancy; Streptococcal Infections; Streptococcus anginosus; Surgical Wound Dehiscence; Uterus; Vasculitis | 2011 |
High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Clindamycin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Levofloxacin; Middle Aged; Mutation; Ofloxacin; Prevalence; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Tetracycline | 2013 |
Fluoroquinolone resistance in Streptococcus pyogenes.
Topics: Amino Acid Substitution; Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcal Infections; Streptococcus pyogenes | 2003 |
[Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Levofloxacin; Ofloxacin; Penicillins; Retrospective Studies; Spain; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Floxacillin; Fluoroquinolones; Infusions, Intravenous; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2004 |
High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
Topics: Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroquinolones; Germany; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; Polymerase Chain Reaction; Population Surveillance; Streptococcal Infections; Streptococcus pyogenes; Wound Infection | 2004 |
Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.
Topics: Amino Acid Substitution; Anti-Infective Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Carrier Proteins; Ciprofloxacin; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Molecular Epidemiology; Molecular Sequence Data; Ofloxacin; Spain; Streptococcal Infections; Streptococcus pyogenes | 2005 |
Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Biological Availability; Drug Therapy, Combination; Female; Humans; Levofloxacin; Ofloxacin; Polycystic Kidney, Autosomal Dominant; Pyelonephritis; Streptococcal Infections; Streptococcus agalactiae | 2006 |
Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Levofloxacin; Male; Ofloxacin; Spain; Streptococcal Infections; Streptococcus pyogenes | 2007 |
Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group.
Topics: Anti-Infective Agents; Bacteremia; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Penicillins; Streptococcal Infections; Streptococcus pneumoniae | 1996 |
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae | 1997 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae | 1998 |
Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
Topics: Animals; Aortic Valve; Drug Resistance, Microbial; Endocarditis, Bacterial; Heart Valve Diseases; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus sanguis | 1999 |
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Topics: Animals; Anti-Infective Agents; Catheterization; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Rats; Streptococcal Infections; Streptococcus; Streptococcus sanguis; Treatment Outcome | 1999 |
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Norfloxacin; Ofloxacin; Penicillins; Quinolines; Streptococcal Infections; Streptococcus | 2001 |